Search research articles
Contact Us
Filters
Showing results (71-80 of 175) with videos related to
Page
of 18
Sort By:
Internal Medicine (Tokyo, Japan)
|
March 22, 2022
Relationship between the Thyroid Function and Cognitive Impairment in the Elderly in Japan
Sumiko Furuto-Kato, Atsushi Araki, Yuko Chiba, et al.
Biochemical and Biophysical Research Communications
|
September 24, 2008
Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet
Rieko Takanabe, Koh Ono, Yukiko Abe, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 27, 2008
Small dense LDL-cholesterol relative to LDL-cholesterol is a strong independent determinant of hypoadiponectinemia in metabolic syndrome
Noriko Satoh, Hiromichi Wada, Koh Ono, et al.
Clinical Endocrinology
|
October 17, 2019
Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism
Hiroki Kaneko, Hironobu Umakoshi, Yuki Ishihara, et al.
Diabetes Research and Clinical Practice
|
September 24, 2023
Novel pathological implications of serum uric acid with cardiovascular disease risk in obesity
Dai Wakabayashi, Sayaka Kato, Masashi Tanaka, et al.
Journal of Atherosclerosis and Thrombosis
|
June 15, 2016
Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation
Maki Komiyama, Sayaka Shimada, Hiromichi Wada, et al.
Endocrine Journal
|
December 4, 2015
Serum free thyroxine levels are associated with the efficacy of weight reduction therapy in obese female patients
Koshi Hashimoto, Tetsuya Tagami, Hajime Yamakage, et al.
Metabolism: Clinical and Experimental
|
October 16, 2012
A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients
Noriko Satoh-Asahara, Yousuke Sasaki, Hiromichi Wada, et al.
Frontiers in Endocrinology
|
April 11, 2024
Five percent weight loss is a significant 1-year predictor and an optimal 5-year cut-off for reducing the number of obesity-related cardiovascular disease risk components: the Japan Obesity and Metabolic Syndrome Study
Hajime Yamakage, Takaaki Jo, Masashi Tanaka, et al.
Plos One
|
August 31, 2013
Analysis of factors that determine weight gain during smoking cessation therapy
Maki Komiyama, Hiromichi Wada, Shuichi Ura, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 175) with videos related to
Sort By:
Page
of 18
Internal Medicine (Tokyo, Japan)
|
March 22, 2022
Relationship between the Thyroid Function and Cognitive Impairment in the Elderly in Japan
Sumiko Furuto-Kato, Atsushi Araki, Yuko Chiba, et al.
Biochemical and Biophysical Research Communications
|
September 24, 2008
Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet
Rieko Takanabe, Koh Ono, Yukiko Abe, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
May 27, 2008
Small dense LDL-cholesterol relative to LDL-cholesterol is a strong independent determinant of hypoadiponectinemia in metabolic syndrome
Noriko Satoh, Hiromichi Wada, Koh Ono, et al.
Clinical Endocrinology
|
October 17, 2019
Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism
Hiroki Kaneko, Hironobu Umakoshi, Yuki Ishihara, et al.
Diabetes Research and Clinical Practice
|
September 24, 2023
Novel pathological implications of serum uric acid with cardiovascular disease risk in obesity
Dai Wakabayashi, Sayaka Kato, Masashi Tanaka, et al.
Journal of Atherosclerosis and Thrombosis
|
June 15, 2016
Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation
Maki Komiyama, Sayaka Shimada, Hiromichi Wada, et al.
Endocrine Journal
|
December 4, 2015
Serum free thyroxine levels are associated with the efficacy of weight reduction therapy in obese female patients
Koshi Hashimoto, Tetsuya Tagami, Hajime Yamakage, et al.
Metabolism: Clinical and Experimental
|
October 16, 2012
A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients
Noriko Satoh-Asahara, Yousuke Sasaki, Hiromichi Wada, et al.
Frontiers in Endocrinology
|
April 11, 2024
Five percent weight loss is a significant 1-year predictor and an optimal 5-year cut-off for reducing the number of obesity-related cardiovascular disease risk components: the Japan Obesity and Metabolic Syndrome Study
Hajime Yamakage, Takaaki Jo, Masashi Tanaka, et al.
Plos One
|
August 31, 2013
Analysis of factors that determine weight gain during smoking cessation therapy
Maki Komiyama, Hiromichi Wada, Shuichi Ura, et al.
Page
of 18